Augusta University
Augusta University’s Sickle Cell Transition Program was recently awarded $50,000 from Global Blood Therapeutics, Inc., through the company’s 2020 Access to Excellent Care for Sickle Cell Patients (ACCEL) grant program.
Consider these news story ideas for your Black History Month coverage.
“I definitely see the importance of regional hospitals. When communities lose regional hospitals, communities die.”
Life is never the same for a child diagnosed with sickle cell disease. They must learn the strategies necessary to live a normal live with an uncommon condition. The National Heart, Lung, and Blood Institute estimates between 90,000 – 100,000...
